Experience of pandemic influenza with H1N1 in children with leukemia

Pediatric Hematology and Oncology

Volumn 28, Issue 1, 2011, Pages 31-36

  Karapinar, Deniz Yilmaz ^a   Ay, Yilmaz ^a   Karzaoǧlu, Zeynep ^a   Balkan, Can ^a   Ergin, Firat ^a   Vardar, Fadil ^a   Kavakli, Kaan ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

acute leukemias; children; oseltamivir; pandemic influenza; vaccination

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CEPHALOSPORIN DERIVATIVE; INFLUENZA VACCINE; METHOTREXATE; OSELTAMIVIR; SULPERAZON;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BRONCHOPNEUMONIA; CANCER COMBINATION CHEMOTHERAPY; CELL CULTURE; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; COUGHING; DIARRHEA; DRUG MEGADOSE; DRUG SAFETY; FEBRILE NEUTROPENIA; FEMALE; FEVER; HIGH RISK PATIENT; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HUMAN CELL CULTURE; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INTENSIVE CARE; INTENSIVE CARE UNIT; MAINTENANCE THERAPY; MALE; PANDEMIC INFLUENZA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RESPIRATORY DISTRESS; RHINORRHEA; SCHOOL CHILD; SKULL IRRADIATION; STOMACH PAIN; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MALE; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 79952137198     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2010.521541     Document Type: Article

References (16)

1. World Health Organization (WHO). Pandemic (H1N1) 2009 update. 2009. Available at: http://wwwwhoint/csr/don/2009-09-11/en/indexhtml. Accessed September 14, 2009.
2. Garten RJ, Davis CT, Russell CA, et al.. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009;325:197-201.
3. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawwood DF, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605-2615.
4. Centers for Disease Control and Prevention (CDC). Hospitalized patients with novel influenza A (H1N1) virus infection California, April-May, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:536-541.
5. Centers for Disease Control and Prevention (CDC). H1N1 vaccination recommendations. 2009. CMAJ. 2010;182:257-264.
6. Launes C, Rives S, Catala A, et al.. Pandemic influenza A (2009 H1N1) in children with acute lymphoblastic leukemia. Br J Haematol. 2010;149:874-878.
7. Caselli D, Carraro F, Castagnola E, et al.. Morbidity of pandemic H1N1 influenza in children with cancer. Pediatr Blood Cancer. 2010;55:226-228.
8. Moricke A, Reiter A, Zimmermann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment result of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood. 2008;111:4477-4489.
9. Creutzig U, Zimmermann M, Lehrnbecher T, et al. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. J Clin Oncol. 2006;24:4499-4506. (Pubitemid 46646248)
10. Kharfan-Dabaja MA, Velez A, Richards K, et al. Inflluenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population. Int J Hematol. 2010;91:124-127.
11. The Health Ministry of Republic of Turkey. Pandemic influenza A (H1N1) bulletin. Available at: http://www.saglik.gov.tr. Accessed January 5, 2010.
12. O'Riordan S, Barton M, Yau Y, et al. Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ. 2010;182:39-44.
13. Morgan OW, Bromley A, Fowlken A, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A (H1N1) disease. PloS ONE. 2010;5:e9694.
14. CDC. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. Available at: http://www.cdc.gov/h1n1flu/recommendations.htm. Last accessed October 22, 2009.
15. European Centre for Disease Prevention and Control (ECDC). On public health use of influenza antivirals during influenza pandemics (with particular reference to the pandemic (H1N1) 2009). Available at: http://www.ecdc.europa.eu/ en/healthtopics/Documents/ 0908 Influenza A H1N1 On Public Health Use of Influenza Antivirals during Influenza Pandemics.pdf. Last accessed October 22, 2009.
16. WHO. WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. Available at: http://www.who.int/ entity/csr/resources/publications/swineflu/h1n1-guidelinespharmaceuticalmngt. pdf. Last accessed October 22, 2009.